These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3303389)

  • 1. [Salvage treatment of non-Hodgkin's lymphomas].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(2):211-24. PubMed ID: 3303389
    [No Abstract]   [Full Text] [Related]  

  • 2. Cladribine for the treatment of indolent non-Hodgkin's lymphomas.
    Hoffman MA
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):40-4. PubMed ID: 8714616
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bortezomib in B-cell non-Hodgkin's lymphoma.
    Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?
    Rodriguez J
    Nat Clin Pract Oncol; 2005 Feb; 2(2):74-5. PubMed ID: 16264876
    [No Abstract]   [Full Text] [Related]  

  • 6. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
    Rossi JF
    Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
    [No Abstract]   [Full Text] [Related]  

  • 7. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
    Piro LD
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615
    [No Abstract]   [Full Text] [Related]  

  • 8. Salvage radiotherapy in patients with PET-Positive residual non-Hodgkin's lymphoma after chemotherapy: in regard to Kahn et al. (Int J Radiat Oncol Biol Phys 2006;66:961-965).
    Nieder C; Andratschke N
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1278; author reply 1278. PubMed ID: 17336228
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials referral resource. Clinical trials in non-Hodgkin's Lymphoma.
    Cheson BD; Smiley JK
    Oncology (Williston Park); 1998 Sep; 12(9):1321-2, 1327. PubMed ID: 9778678
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapeutic palliative approaches in the treatment of lymphoma.
    Vose JM
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):53-7. PubMed ID: 7537905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
    Akhtar S; Maghfoor I
    J Clin Oncol; 2005 Sep; 23(25):6261; author reply 6262. PubMed ID: 16135496
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction between statins and rituximab in non-Hodgkin's lymphoma.
    Rabinowitz I
    J Clin Oncol; 2008 Nov; 26(33):5486; author reply 5486. PubMed ID: 18936467
    [No Abstract]   [Full Text] [Related]  

  • 13. Cladribine in indolent non-Hodgkin's lymphoma.
    Sigal DS; Saven A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):535-45. PubMed ID: 18402520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?].
    Hansen PB; Jensen MK
    Ugeskr Laeger; 2007 Jun; 169(23):2187-9. PubMed ID: 17592682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody therapy for non-Hodgkin's lymphoma.
    Ansell SM
    Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-cytostatic treatment of malignancies. Anti-CD20 monoclonal antibody (Rituximab, Mabthera) in the treatment of non-Hodgkin's lymphoma].
    Mayer J; Navrátil M; Vásová J; Vorlícek J
    Vnitr Lek; 2001 Sep; 47 Suppl 1():57-62. PubMed ID: 11693064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
    Hiddemann W; Unterhalt M; Pott C; Wörmann B; Sandford D; Freund M; Engert A; Gassmann W; Holtkamp W; Seufert J
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
    Aurer I; Mitrović Z; Radman I; Kovacević-Metelko J; Nemet D; Serventi-Seiwerth R; Stern-Padovan R; Jakic-Razumović J; Nola M; Zupancić-Salek S; Sertić D; Labar B
    Lijec Vjesn; 2004; 126(11-12):307-11. PubMed ID: 16082888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
    Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.